Search results for "Ganglioneuroblastoma"

showing 4 items of 4 documents

Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors

2014

Childhood neuroblastic tumors are characterized by heterogeneous clinical courses, ranging from benign ganglioneuroma (GN) to highly lethal neuroblastoma (NB). Although a refined prognostic evaluation and risk stratification of each tumor patient is becoming increasingly essential to personalize treatment options, currently only few biomolecular markers (essentially MYCN amplification, chromosome 11q status and DNA ploidy) are validated for this purpose in neuroblastic tumors. Here we report that Galectin-3 (Gal-3), a β-galactoside-binding lectin involved in multiple biological functions that has already acquired diagnostic relevance in specific clinical settings, is variably expressed in m…

0301 basic medicineMaleCancer ResearchPathologyTime FactorsCellular differentiationGalectin 3ApoptosisPredictive Value of TestKaplan-Meier EstimateNeuroblastoma0302 clinical medicineRisk FactorsChildGanglioneuroblastomaGanglioneuroblastomaCell DifferentiationBlood ProteinsNeuroblastic TumorPhenotypeImmunohistochemistry3. Good healthGalectin-3030220 oncology & carcinogenesisChild PreschoolImmunohistochemistryOriginal ArticleFemaleHumanmedicine.medical_specialtyAdolescentTime FactorSchwannian stromaGalectinsImmunologyBiologyTransfectionNeural cell differentiationschwannian stroma; neuroblastoma prognostic factor; neural cell differentiation; neuroblastoma03 medical and health sciencesCellular and Molecular NeurosciencePredictive Value of TestsNeuroblastomaCell Line TumormedicineBiomarkers TumorCell AdhesionHumansGanglioneuromaNeuroblastoma prognostic factorCell ProliferationNeoplasm StagingRisk FactorInfant NewbornApoptosiInfantGanglioneuromaCell Biologymedicine.disease030104 developmental biologyCancer research
researchProduct

Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic st…

2006

Purpose To assess the prognostic value of clinical, biologic, and morphologic data in peripheral neuroblastic tumors, International Neuroblastoma Staging System (INSS) stages 2A and 2B MYCN nonamplified, a multinational protocol entitled Localized Neuroblastoma European Study Group trial 94.01, with a trial of surgery as the only treatment, was initiated in 1995. We present the prognostic value of the revised International Neuroblastoma Pathology Classification (INPC) applied to the patients included in this protocol until its closure in 1999. Materials and Methods A total of 120 neuroblastic tumors from trial patients were reviewed by the European International Society of Pediatric Oncolog…

Cancer Researchmedicine.medical_specialtyPathologyDisease-Free SurvivalNeuroblastomaPredictive Value of TestsNeuroblastomamedicineHumansSurvival analysisGanglioneuroblastomaL-Lactate Dehydrogenasebusiness.industryGanglioneuroblastomaAnatomical pathologymedicine.diseasePrognosisNeuroblastic TumorSurvival AnalysisClinical trialEuropeTreatment OutcomeOncologyPredictive value of testsHistopathologybusinessJournal of clinical oncology : official journal of the American Society of Clinical Oncology
researchProduct

Incidence, Trends, and Survival of Children With Embryonal Tumors.

2015

BACKGROUND: Central nervous system (CNS) and non-CNS embryonal tumors occur principally in children and are rarely seen in adults. The incidence rates for rare entities such as atypical teratoid/rhabdoid tumors (AT/RT) or primitive neuroectodermal tumors in the CNS are rarely published. Incidence rates for certain subgroups, such as hepatoblastomas, have been increasing in some countries. METHODS: Data of 8337 embryonal tumors, registered in children (0–14 years) between 1991 and 2012 (for AT/RT 2000–2012) in the population-based German Childhood Cancer Registry with complete national coverage were analyzed for incidence rates, time trends, and survival. RESULTS: For most entities, the inc…

MalePediatricsmedicine.medical_specialtyHepatoblastomaAdolescentPopulationCentral Nervous System NeoplasmsGermanyMedicineHumansRegistrieseducationChildSurvival rateGanglioneuroblastomaeducation.field_of_studyChildhood Cancer Registrybusiness.industryRetinoblastomaIncidence (epidemiology)IncidenceInfant NewbornInfantNeoplasms Germ Cell and Embryonalmedicine.diseaseCancer registrySurvival RateChild PreschoolPediatrics Perinatology and Child HealthFemalebusinessPediatrics
researchProduct

Plexiform Atypical Spitz Tumor With Rosette-Like Giant Cells. A Histologic and Immunohistochemical Study on a Case Suggesting Ganglioneuroblastic Dif…

2018

Spitz nevi, atypical Spitz tumors and Spitzoid melanoma, the three clinicopathologic forms that constitute the spectrum of the Spitz-type melanocytic lesions, share a histologic picture characterized by large spindle and/or epithelioid ganglion-like cells, with various admixtures of multinucleate bizarre cells. This remarkable cytology has always been interpreted as an unusual, as well as unexplained form of atypia. We report a case of atypical Spitz tumor with Homer Wright-like rosettes, a feature characteristic of ganglioneuroblastic proliferation. Furthermore, the ganglion-like cells of the tumor showed basophilic punctuation in the cytoplasm, reminiscent of Nissl substance, and a few ce…

Pathologymedicine.medical_specialtySkin NeoplasmsAdolescentCellular differentiationDermatologyHistogenesisBiologyGiant CellsPathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineNevus Epithelioid and Spindle CellBiomarkers TumormedicineAtypiaSettore MED/35 - Malattie Cutanee E VenereeHumansNevusSpitz tumors Homer Wright–like rosettes ganglionlike cells ganglioneuroblastic differentiationGanglioneuromaGanglioneuroblastomaNeural crestCell DifferentiationGeneral Medicinemedicine.diseaseImmunohistochemistryGiant cell030220 oncology & carcinogenesisFemale
researchProduct